Log in

LON:SPHSINR PHAR/PAR VTG FPD 0.01 Share Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range
31.80
MA: GBX 31.80
31.80
52-Week Range N/A
VolumeN/A
Average Volume764,933 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sinclair Pharma plc, a specialty pharmaceutical company, engages in the manufacture, commercialization, and sale of dermatological products worldwide. It provides Silhouette Soft, a resorbable poly-L-lactic acid(PLLA)/PLGA suture with bi-directional resorbable cones for skin repositioning and tightening; and Ellansé, which offers dermal fillers. The company also provides Perfectha for wrinkle correction, facial contouring, and volume restoration; and Sculptra designed to stimulate collagen growth. It serves healthcare providers and plastic surgeons. The company was formerly known as Sinclair IS Pharma plc and changed its name to Sinclair Pharma plc in December 2015. Sinclair Pharma plc was founded in 1971 and is headquartered in London, the United Kingdom.
Read More
SINR PHAR/PAR VTG FPD 0.01 logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.64 out of 5 stars


Industry, Sector and Symbol

Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-20-74676920

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableOptionable

Receive SPH News and Ratings via Email

Sign-up to receive the latest news and ratings for SPH and its competitors with MarketBeat's FREE daily newsletter.

SINR PHAR/PAR VTG FPD 0.01 (LON:SPH) Frequently Asked Questions

Has SINR PHAR/PAR VTG FPD 0.01 been receiving favorable news coverage?

Media coverage about SPH stock has trended somewhat negative this week, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of media coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. SINR PHAR/PAR VTG FPD 0.01 earned a coverage optimism score of -1.0 on InfoTrie's scale. They also assigned media coverage about the specialty pharmaceutical company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the company's share price in the next several days. View the latest news aboutSINR PHAR/PAR VTG FPD 0.01.

Who are some of SINR PHAR/PAR VTG FPD 0.01's key competitors?

Some companies that are related to SINR PHAR/PAR VTG FPD 0.01 include Bayer (BAYN), HedgePath Pharmaceuticals (MAYNF), OTSUKA HOLDINGS/ADR (OTSKY), Roche (RHHVF), Roche (SNYNF) and Sanofi (SAN). View all competitors.

What other stocks do shareholders of SINR PHAR/PAR VTG FPD 0.01 own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SINR PHAR/PAR VTG FPD 0.01 investors own include Vectura Group (VEC), Energy Transfer LP Unit (ET), Hikma Pharmaceuticals (HIK), Aryzta (ARYN), ASOS (ASC), Bayer (BAYN), Cracker Barrel Old Country Store (CBRL), Celgene (CELG), Clariant (CLN) and Jack in the Box (JACK).

Who are SINR PHAR/PAR VTG FPD 0.01's key executives?

SINR PHAR/PAR VTG FPD 0.01's management team includes the following people:
  • Mr. Christopher P. Spooner, CEO & Exec. Director
  • Mr. Alan Musgrave Olby, CFO & Director (Age 47)
  • Ms. Jayne Burrell, Group Gen. Counsel & Company Sec. (Age 43)
  • Ms. Emilie Croissant, Head of Europe & Global Marketing
  • Mr. Nairn McMaster, Head of Latin America

What is SINR PHAR/PAR VTG FPD 0.01's stock symbol?

SINR PHAR/PAR VTG FPD 0.01 trades on the London Stock Exchange (LON) under the ticker symbol "SPH."

How do I buy shares of SINR PHAR/PAR VTG FPD 0.01?

Shares of SPH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is SINR PHAR/PAR VTG FPD 0.01's official website?

The official website for SINR PHAR/PAR VTG FPD 0.01 is www.sinclairispharma.com.

How can I contact SINR PHAR/PAR VTG FPD 0.01?

SINR PHAR/PAR VTG FPD 0.01's mailing address is 1st Fl Whitfield Court, 30-32 Whitfield Street, LONDON, W1T 2RQ, United Kingdom. The specialty pharmaceutical company can be reached via phone at +44-20-74676920.

This page was last updated on 5/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.